455
Views
5
CrossRef citations to date
0
Altmetric
Articles

A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors

, , , , , , , , & show all

References

  • Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet. 2003;362(9377):22–29.10.1016/S0140-6736(03)13802-0
  • Barber TJ, Hughes A, Dinsmore WW, Phillips A. How does HIV impact on non-AIDS events in the era of HAART?. Int J STD AIDS. 2009;20(1):1–3.10.1258/ijsa.2008.008302
  • Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506–2512.10.1210/jc.2006-2190
  • Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625–1631.10.1086/518285
  • Phillips AN, Carr A, Neuhaus J, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther. 2008;13(2):177–187.
  • Lundgren JD, Reiss P, Worm SW, et al. Risk of myocardial infarction with exposure to specific ARV from the PI, NNRTI, and NRTI drug classes: the D:A:D study. CROI, Montreal, 2009.
  • Kundur A, Singh I, Bulmer A. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert’s syndrome? Atherosclerosis. 2015;239(1):73–84.10.1016/j.atherosclerosis.2014.12.042
  • Mazzone GL, Rigato I, Ostrow JD, et al. Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun. 2009;386:338–344.10.1016/j.bbrc.2009.06.029
  • Basiglio CL, Arriaga SM, Pelusa F, Almara AM, Kapitulnik J, Mottino AD. Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci. 2010;118:99–11310. doi:10.1042/CS20080540.
  • Vítek L, Malíková I, Kvasnička J, Benáková H, Novotný L. Relationship between serum bilirubin and markers of inflammation and oxidative stress. J Gastroenterol Hepatol. 2007;22:A235–A235. doi:10.1111/j.1440-1746.2006.04564.x.
  • Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med. 2011;49:1823–1828. doi:10.1515/cclm.2011.662.
  • Yoshino S, Hamasaki S, Ishida S, et al. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb. 2011;18:403–412. doi:10.5551/jat.6346.
  • Yoshino S, Hamasai S, Ishida S, et al. Effect of serum concentration of bilirubin in the obese patients: the action for coronary endothelial function and inflammatory stress. J Am Coll Cardiol. 2010;55:E1434.
  • Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184(2):431–437.10.1016/j.atherosclerosis.2005.05.011
  • Scourfield A, Waters L, Jones R, et al. The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals. 17th Annual BHIVA Conference, 6–8 April 2011, Bournemouth. Oral abstract O33.
  • D:A:D Study Group. The use of the Framingham equation to predict myocardial infarctions in HIV infected patients: comparison with observed events in the D:A:D Study. HIV Med. 2006 May;7(4):218–230.
  • Grunfeld C, Delaney J, Wanke C, FRAM Study. HIV infection is an independent risk factor for atherosclerosis similar in magnitude to traditional cardiovascular disease risk factors, CROI 2009, abstract 146.
  • Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15.10.1161/hy0102.099031
  • Mattace-Raso F, van der Cammen TJM, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the rotterdam study. Circulation. 2006;113:657–663.10.1161/CIRCULATIONAHA.105.555235
  • Guo W, Liao C, Zou Y, et al. Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med. 2010;7(8):2805–2816.
  • Hall SA, Shackelton R, Rosen RC, Araujo AB. Sexual activity, erectile dysfunction, and incident cardiovascular events. Am J Cardiol. 2010Jan 15;105(2):192–197.10.1016/j.amjcard.2009.08.671
  • Chew KK, Finn J, Stuckey B, et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med. 2010 Jan;7:192–202.
  • Araujo AB, Hall SA, Ganz P, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the framingham risk score? J Am Coll Cardiol. 2010 Jan 26;55(4):350–356.10.1016/j.jacc.2009.08.058
  • Dao C, Young B, Buchacz K, Baker R, Brooks J. The HIV Outpatient Study Investigators. Higher and increasing rates of fracture among HIV-infected persons in the HIV outpatient study compared to the general US population, 1994 to 2008. Program of the 17th Conference of Retrovirus and Opportunistic Infections 2010, San Franciso. Oral 128.
  • McComsey G, Kitch D, Daar E, et al. Bone and limb fat outcomes of ACTG A5224s, a substudy of ACTG A5202: a prospective, randomized, partially blinded phase III trial of ABC/3TC or TDF/FTC with EFV or ATV/r for initial treatment of HIV-1 infection. Program of the 17th Conference on Retroviruses and Opportunistic Infections 2010, San Franciso. Abstract 106LB.
  • Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–1259.10.1136/bmj.312.7041.1254
  • Stein JH, Hodis HN, Brown TT, et al. Prospective Randomized clinical trial of the effects of three modern antiretroviral therapies on carotid intima-media thickness in HIV-infected individuals (ACTG A5260s). J Am Coll Cardiol. 2014;63(12_S).
  • Asboe D, Catalan J, Mandalia S, et al. Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care. 2007 Sep;19(8):955–965.10.1080/09540120701209847
  • Rosen RC, Cappelleri JC, Gendrano N. The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244.10.1038/sj.ijir.3900857
  • Coyne K, Mandalia S, McCullough S, et al. The international index of erectile function: development of an adapted tool for use in HIV-positive men who have sex with men. J Sex Med. 2010 Feb;7(2 Pt 1):769–774.
  • www.europeanaidsclinicalsociety.org/guidelinespdf/2_Non_Infectious_Co_Morbidities_in_HIV.pdf.
  • Hans D, Dargent-Molina P, Schoot AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. The Lancet. 1996;348:511–514.10.1016/S0140-6736(95)11456-4
  • Krieg M-A, Cornuz J, Ruffieux C, et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women >=70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. JBMR. 2006;21(9):1457–1463.
  • Glüer CC, Eastell R, Reid DM, et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS study. JBMR. 2004;19(5):782–793.
  • Frediani B, Acciai C, Falsetti P, et al. Calcaneus ultrasonometry and dual-energy X-Ray absorptiometry for the evaluation of vertebral fracture risk. Calcif Tissue Int. 2006;79:223–229.10.1007/s00223-005-0098-4
  • Hartl F, Tyndall A, Kraenzlin M, et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the basel osteoporosis study. J Bone Miner Res. 2002 Feb;17(2):321–330.10.1359/jbmr.2002.17.2.321

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.